Page last updated: 2024-08-25

nipradilol and Injury, Myocardial Reperfusion

nipradilol has been researched along with Injury, Myocardial Reperfusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horimoto, H; Maeda, K; Mieno, S; Nakai, Y; Ohtsuka, T; Suematsu, Y; Takamoto, S	1

Other Studies

1 other study(ies) available for nipradilol and Injury, Myocardial Reperfusion

Article	Year
Long-term treatment with nipradilol, a nitric oxide-releasing beta-adrenergic blocker, enhances postischemic recovery and limits infarct size. The Annals of thoracic surgery, 2002, Volume: 73, Issue:1 Topics: Adrenergic beta-Antagonists; Animals; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure	2002

Article

Year

Long-term treatment with nipradilol, a nitric oxide-releasing beta-adrenergic blocker, enhances postischemic recovery and limits infarct size.

The Annals of thoracic surgery, 2002, Volume: 73, Issue:1

Topics: Adrenergic beta-Antagonists; Animals; In Vitro Techniques; Ischemic Preconditioning, Myocardial; Lipid Peroxidation; Male; Myocardial Infarction; Myocardial Reperfusion Injury; Propanolamines; Rats; Rats, Wistar; Ventricular Function, Left; Ventricular Pressure

2002